Ezetimibe Ameliorates Ankylosing Spondylitis by Suppressing Th17 Differentiation
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接：
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE205850
下载链接
链接失效反馈官方服务：
资源简介：
Oxidized low-density lipoprotein influences the Th17/Treg balance. A high serum concentration of oxidized low-density lipoprotein is negatively correlated with the number of Treg cells and positively correlated with the number of Th17 cells. Therefore, we expected that the reduction of blood lipid levels using ezetimibe and statin would ameliorate AS disease by reducing the number of Th17 cells. total 16 samples Samples of Th0 condition: 4 Samples of Th17 condition: 4 Samples of Ezetimibe with Th17 condition: 4 Samples of Rosuvastatin with Th17 condition: 4
创建时间：
2022-09-15
